和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

圣诞节休市 12-24 12:08:24

13.020

-0.110

-0.84%

最高13.200	最低12.820	成交量173.38万
今开13.200	昨收13.130	日振幅2.89%
总市值113.35亿	流通市值113.35亿	总股本8.71亿
成交额2,253万	换手率0.20%	流通股本8.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":13.02,"timestamp":1766549304002,"preClose":13.13,"halted":0,"volume":1733844,"delay":0,"floatShares":870560722,"shares":870560722,"eps":0.028119070577622945,"marketStatus":"圣诞节休市","change":-0.11,"latestTime":"12-24 12:08:24","open":13.2,"high":13.2,"low":12.82,"amount":22526799,"amplitude":0.028941,"askPrice":13.02,"askSize":5000,"bidPrice":13.01,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":0.7163597623565274,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":13.13,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.6851045115464721,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2594287939","title":"光鲜下的另一面，BD交易后股价不涨反跌成常态？专家：短期热度降低不是坏事","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287939","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287939?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:21","pubTimestamp":1766643688,"startTime":"0","endTime":"0","summary":"今年创新药企业频繁宣布BD交易，但从三季度以来，原本利好的消息却不被二级市场买账。最近一周，BD交易再掀一个小高潮。12月22日，先声药业（02096.HK）宣布其附属公司江苏再明与Ipsen于12月19日签订独家授权许可协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601825588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","LU1997244956.HKD","LU1146622755.USD","03692","LU1064131003.USD","09995","LU1997245177.USD","BK1589","BK0188","02509","LU0405327494.USD","BK0012","LU0405327148.USD","LU1781817850.SGD","BK0057","LU2097828474.EUR","01167","603087","BK0060","BK1593","BK1161","LU2495084118.USD","LU2488822045.USD","LU2097828557.USD","BK1574","000661","688428","688062","LU0502904849.HKD","BK0183","688336","BK0239","LU2097828631.EUR","02096","LU2148510915.USD","600276","002755","LU2097828714.EUR","LU1969619763.USD","02142","BK0028","BK0196","LU2580892862.HKD","01530","LU1328615791.USD","06978","688331","01801","LU2097828805.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2593447421","title":"每日卖空追踪 | 和铂医药-B 12月24日卖空量成交38.2万股，卖空比例为22.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447421","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447421?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565025,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间12月24日，跌0.84%，卖空量成交38.2万股，较上一交易日减少29.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163412a4727fc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163412a4727fc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2593042849","title":"和铂医药-B12月23日主力净流出500.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593042849","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593042849?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:16","pubTimestamp":1766477761,"startTime":"0","endTime":"0","summary":"12月23日, 和铂医药-B股价跌0.45%，报收13.13元，成交金额4546.1万元，换手率0.40%，振幅3.11%，量比0.59。和铂医药-B今日主力资金净流出500.5万元，上一交易日主力净流入76.0万元。该股近5个交易日上涨1.08%，主力资金累计净流入20.2万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3307.8万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162231a6c51001&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162231a6c51001&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02142","BK1574","BK1161"],"gpt_icon":0},{"id":"2593936724","title":"2025年岁末，国产创新药出海热潮再起！涉及先声药业、荃信生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2593936724","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593936724?lang=zh_cn&edition=full","pubTime":"2025-12-23 09:42","pubTimestamp":1766454156,"startTime":"0","endTime":"0","summary":"2025年进入12月，国产创新药出海热潮再次掀起。如12月22日，先声药业发布公告，与Ipsen签订了独家授权许可协议，涉及其开发的抗体药物偶联物SIM0613。此外，长春高新、复星医药等多家药企均在本月宣布达成创新药授权合作。从单个企业的零星出海，到产业层面的批量突围，2025年岁末的国产创新药出海热潮，标志着中国医药创新已站在新的历史起点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223094420a46c9ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223094420a46c9ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","02142","BK1161","02509","02096","BK1583","06978"],"gpt_icon":0},{"id":"2593842431","title":"每日卖空追踪 | 和铂医药-B 12月22日卖空量成交54.6万股，卖空比例为10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593842431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593842431?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392228,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间12月22日，跌1.12%，卖空量成交54.6万股，较上一交易日减少73.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163518a6c09c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163518a6c09c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2592113184","title":"每日卖空追踪 | 和铂医药-B 12月19日卖空量成交48万股，卖空比例为8.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592113184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592113184?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133027,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间12月19日，涨6.63%，卖空量成交48万股，较上一交易日减少67.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163422a45f3583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163422a45f3583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2592659081","title":"和铂医药-B12月19日主力净流入448.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592659081","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592659081?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132146,"startTime":"0","endTime":"0","summary":"12月19日, 和铂医药-B股价涨6.63%，报收13.34元，成交金额9229.0万元，换手率0.80%，振幅8.87%，量比1.25。和铂医药-B今日主力资金净流入448.1万元，上一交易日主力净流出364.9万元。该股近5个交易日上涨0.15%，主力资金累计净流入144.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3989.4万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161940a6b63211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161940a6b63211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02142","BK1161"],"gpt_icon":0},{"id":"2592659731","title":"兴业证券：实体瘤TCE技术路径百花齐放 国内企业创新平台布局丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2592659731","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592659731?lang=zh_cn&edition=full","pubTime":"2025-12-19 14:08","pubTimestamp":1766124536,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兴业证券发布研报称，TCE在血液瘤中的疗效与商业化能力已充分验证，但还需解决几大问题。非全长双抗、2+1格式设计、TCR、前药、共刺激靶点与选择性T细胞靶点等设计进一步增强TCE在实体瘤的适用性。国内公司CD28共刺激多抗、TCEADC、位阻遮蔽设计、TCR疗法等形式的实体瘤TCE研发持续推进，已形成平台化的研发能力与靶点布局丰富的管线梯队。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219144108a45ebf21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219144108a45ebf21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1574","BK1583","02696","BK1161"],"gpt_icon":0},{"id":"2592067131","title":"和铂医药-B(02142.HK)早盘一度涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592067131","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592067131?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:43","pubTimestamp":1766112220,"startTime":"0","endTime":"0","summary":"每经AI快讯，和铂医药-B(02142.HK)早盘一度涨超8%，截至发稿涨6.79%，报13.36港元，成交额2520.71万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512193596562450.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512193596562450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2592396131","title":"港股异动 | 和铂医药-B(02142)早盘涨超8% 公司与百时美施贵宝签订超10亿美元BD交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2592396131","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592396131?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:29","pubTimestamp":1766111351,"startTime":"0","endTime":"0","summary":"消息面上，和铂医药发布公告称，公司与百时美施贵宝已订立多年全球战略合作及授权协议，旨在发现及开发新一代多特异性抗体。根据协议，和铂医药将获得一笔总额为0.9亿美元的首付款，若百时美施贵宝推进所有潜在项目，公司还有资格获得最高达10.35亿美元的开发及商业里程碑付款以及分级特许权使用费。据悉，和铂医药累计与MNC达成合作已达七次，对外合作总金额超100亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1670710588.SGD","LU1291159041.SGD","LU1074936037.SGD","LU2360032135.SGD","LU0114720955.EUR","LU0985481810.HKD","BK4581","LU2125154935.USD","IE00B2B36J28.USD","IE00BFXG1179.USD","LU0321505439.SGD","BK4532","LU0321505868.SGD","BK4588","LU0225284248.USD","LU2133065610.SGD","LU0096364046.USD","LU1670711040.USD","LU0456855351.SGD","LU1093756325.SGD","BMY","LU0267386448.USD","BK4007","LU0237698245.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU2242646821.SGD","IE0002141913.USD","LU1261432733.SGD","BK4585","LU1032466523.USD","LU0868494617.USD","LU1868836591.USD","LU2242652126.USD","IE00BSNM7G36.USD","02142","LU1868837300.USD","LU0225771236.USD","LU1323610961.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","BK4559","LU0061475181.USD","LU1718418525.SGD","LU0306806265.USD","LU1430594728.SGD","LU1868836757.USD","LU0882574055.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2592150520","title":"海外消费周报：海外教育：教育行业26年投资策略-景气与困境反转交织 投资机会纷呈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592150520","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592150520?lang=zh_cn&edition=full","pubTime":"2025-12-19 00:00","pubTimestamp":1766073600,"startTime":"0","endTime":"0","summary":"海外教育：景气与困境反转交织，投资机会纷呈——教育行业26 年投资策略基本面触底叠加政策推进，高教困境反转可期。教培行业特许经营，强品牌强增长。通过梳理各地白名单机构我们发现，获发办学牌照的均是具备教研实力，长期运营经验的机构，行业特许经营的模式逐步清晰，行业集中度有望持续提升。我们判断教培从完全市场化竞争走向“特许经营”后正规机构将加速产能扩张，从而实现营收和利润的高增。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219172137a6b67ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219172137a6b67ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00839","BK1595","02142","BK1228","01765","BK1556"],"gpt_icon":0},{"id":"2592736909","title":"“港股BD之王”拿大单，金额或超11亿美元！股价不涨反跌，公司：大部分收入明年确认","url":"https://stock-news.laohu8.com/highlight/detail?id=2592736909","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592736909?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:49","pubTimestamp":1766044151,"startTime":"0","endTime":"0","summary":"在今年先后宣布与阿斯利康、日本制药巨头大冢制药达成合作后，和铂医药-B（02142.HK）再度宣布与百时美施贵宝（BMS）的合作。12月17日，和铂医药发布公告称，公司与百时美施贵宝达成长期全球战略合作及许可协议，双方将共同研发新一代多特异性抗体疗法。根据协议条款，和铂医药将与百时美施贵宝合作推进及加速多特异性抗体发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595419049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4231","BK1574","BMS","BK1583","BK4080","02142","ADC"],"gpt_icon":0},{"id":"2592691721","title":"每日卖空追踪 | 和铂医药-B 12月17日卖空量成交159.8万股，卖空比例为19.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592691721","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592691721?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960227,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间12月17日，跌1.15%，卖空量成交159.8万股，较上一交易日增加61.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163410a45612bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163410a45612bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1583","02142"],"gpt_icon":0},{"id":"1134906476","title":"异动解读 | 和铂医药-B盘中大跌5.16%，市场对与百时美施贵宝合作反应谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1134906476","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134906476?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:04","pubTimestamp":1765937067,"startTime":"0","endTime":"0","summary":"和铂医药-B(02142)今日盘中大跌5.16%，引发市场关注。这一股价波动出现在公司与百时美施贵宝宣布达成战略合作之后。根据公告，和铂医药与百时美施贵宝订立了多年全球战略合作及授权协议，共同开发新一代多特异性抗体。和铂医药将获得9000万美元的首付款，若百时美施贵宝推进所有潜在项目，公司还可获得最高达10.35亿美元的里程碑付款及特许权使用费。市场分析人士指出，尽管合作金额可观，但股价下跌可能反映了投资者对合作条款的谨慎态度或对执行风险的担忧。部分投资者可能在利好兑现后选择获利了结，导致股价承压。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02142"],"gpt_icon":0},{"id":"2592526179","title":"港股异动 | 和铂医药-B(02142)仍跌2% 与百时美施贵宝达成全球战略合作 潜在收益超10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592526179","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592526179?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:59","pubTimestamp":1765936773,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B(02142)小幅高开后走低，一度跌超5%，现跌幅收窄。截至发稿，跌2.08%，报12.72港元，成交额3645.09万港元。消息面上，和铂医药今早宣布，与百时美施贵宝达成长期全球战略合作及许可协议，双方将共同研发新一代多特异性抗体疗法。根据协议条款，和铂医药将与百时美施贵宝合作推进及加速多特异性抗体发现项目。和铂医药将获得总计9000万美元的付款，若百时美施贵宝选择推进所有潜在项目，和铂医药还可获得高达10.35亿美元的开发及商业里程碑付款，以及基于未来产品净销售额的分级特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0306806265.USD","LU0061475181.USD","BK1574","LU1868837136.USD","LU1032466523.USD","02142","LU0306807586.USD","LU0114720955.EUR","BK1161","BK4007","LU0321505439.SGD","IE00B2B36J28.USD","LU2242646821.SGD","IE0002141913.USD","LU1868837300.USD","LU0225284248.USD","LU1670711123.USD","LU2125154935.USD","LU1868836914.USD","BMY","LU0321505868.SGD","LU2242652126.USD","BK4534","LU1868836591.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU1868836757.USD","LU2125154778.USD","LU0237698245.USD","LU0225771236.USD","BK4581","BK4532","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU1571399168.USD","LU1323610961.USD","LU1670710588.SGD","LU1718418525.SGD","LU0456855351.SGD","LU1093756168.USD","LU0985481810.HKD","LU1291159041.SGD","BK4588","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1093756325.SGD","LU1585245621.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1117376540","title":"和铂医药-B与施贵宝达成全球战略合作与许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1117376540","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117376540?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:32","pubTimestamp":1765935166,"startTime":"0","endTime":"0","summary":"12月17日（路透社）- 和铂医药-B <2142.HK>::*与施贵宝达成全球战略合作与许可协议*可能将获得总额9000万美元的支付，以及最高达10.35亿美元的发展和商业里程碑*根据协议，双方将合作推进和加速多特异性抗体发现项目*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0267386448.USD","IE00BSNM7G36.USD","LU1868837136.USD","LU0882574055.USD","LU0237698245.USD","IE00BJT1NW94.SGD","BK4588","BMY","IE00B2B36J28.USD","LU0868494617.USD","LU0096364046.USD","IE0009355771.USD","LU2125154935.USD","BK1583","LU1670710661.SGD","02142","BK4581","LU0225284248.USD","LU0306807586.USD","LU1868837300.USD","BK4532","BK4559","LU2242652126.USD","LU1323610961.USD","LU1585245621.USD","LU2125154778.USD","LU1670711040.USD","LU0321505868.SGD","LU1093756168.USD","LU0114720955.EUR","LU0306806265.USD","LU1868836757.USD","LU1261432733.SGD","BK1574","LU2242646821.SGD","LU2360032135.SGD","LU1032466523.USD","LU1989771016.USD","LU2133065610.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0321505439.SGD","LU1670710588.SGD","BK1161","IE0002141913.USD","LU1074936037.SGD","LU1430594728.SGD","BK4007","LU0985481810.HKD","LU1718418525.SGD","LU1868836591.USD","LU1670711123.USD","LU1868836914.USD","LU0225771236.USD","LU0456855351.SGD","LU1093756325.SGD","BK4534","IE00BFTCPJ56.SGD","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"1106678075","title":"和铂医药-B或将获得高达9000万美元的付款，以及高达10.35亿美元的发展和商业里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1106678075","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106678075?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:08","pubTimestamp":1765930123,"startTime":"0","endTime":"0","summary":"和铂医药-B或将获得高达9000万美元的付款，以及高达10.35亿美元的发展和商业里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"1142808094","title":"和铂医药-B与百时美施贵宝达成全球战略合作和许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1142808094","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142808094?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:08","pubTimestamp":1765930094,"startTime":"0","endTime":"0","summary":"和铂医药-B与百时美施贵宝达成全球战略合作和许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"1162129187","title":"和铂医药-B - 根据协议，公司将合作推进和加速多特异性抗体发现项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1162129187","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162129187?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:03","pubTimestamp":1765929790,"startTime":"0","endTime":"0","summary":"和铂医药-B - 根据协议，公司将合作推进和加速多特异性抗体发现项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02142","BK1161","BK1583"],"gpt_icon":0},{"id":"2591963674","title":"每日卖空追踪 | 和铂医药-B 12月15日卖空量成交47.5万股，卖空比例为6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591963674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591963674?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787427,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间12月15日，跌5.43%，卖空量成交47.5万股，较上一交易日减少19.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163419a44d40cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163419a44d40cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02142","BK1161","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0015},{"period":"3month","weight":-0.074},{"period":"6month","weight":0.5744},{"period":"1year","weight":8.1049},{"period":"ytd","weight":6}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。其中，巴托利单抗（HBM9161）主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等. 特那西普（HBM9036）主要用于干眼病。此外，该公司还研究和开发肿瘤免疫产品管线，包括内部开发的新一代肿瘤免疫资产，针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。该公司拥有Harbour Mice平台，该平台能够产生经典的双重链双轻链（H2L2）形式及仅重链（HCAb）形式的全人源单克隆抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.104328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.004171},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.279689}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}